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Abstract 
Purpose: To explore the hypotensive activity and chemical composition of Moringa oleifera Lam 
(Moringaceae) roots. 
Methods: The fresh roots of M. oleifera was cut into small pieces and successively extracted with 
petroleum ether (PE) and dichloromethane (DC). PE extract was further divided into MRP and MRP -1. 
DC extract showed a thick mass during evaporation which was separated as MRDC - IN. The mother 
liquor left was divided into MRDC and MRDC -1. All residues were analyzed by gas chromatography-
mass spectroscopy (GC-MS) using ZB-5 column. Identification of each extract and fraction was based 
on comparison of their retention indices (RI), by co-injecting authentic compounds, as well as by 
comparing literature data available in NIST Standard Reference Database. Hypotensive activity was 
determined on urethane-anesthetized normotensive Sprague Dawly rats.  
Results: Petroleum ether (MRP) and dichloromethane (MRDC) extracts of M. oleifera roots showed 
50.06 ± 3.48 and 48.16 ± 1.79 % fall in mean arterial blood pressure (MABP), respectively, at a dose of 
30 mg/kg (p < 0.01 and p < 0.05, respectively) compared with control. GC-MS analysis of MRP and 
MRDC extracts and fractions resulted in the identification of seventy four (74) compounds. Methyl 
hexadecanoate (7, 20.3 %) , stigmastan - 3, 5, diene (24, 19.32 %), methyl 14-hydroxy-5-
tetradecenoate (9, 19.22 %), 1 , 11 diphenyl undecane (47, 18.78 %) and cyclopentanyl hexadecane 
(39, 14.44 %)  were the major constituents among the various hydrocarbons, fatty acids, esters, 
alcohols, aldehydes, isothiocyanate, aromatics, steroids, terphenyl and sulphur-containing compounds.  
Conclusion: The findings reveal the hypotensive potential of M. oleifera roots and the presence of 
specific hydrocarbons, fatty acid esters, thioureides, steroids and isothiocyanates in active fractions. 
Further study is required to determine the suitability of the plant as an antihypertensive remedy. 
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Moringa oleifera, Lam is one of the best known 
and widely utilized specie among the thirteen 
known species of the monogeneric family 
Moringaceae. It is native to Pakistan and India, 
and widely cultivated throughout the world [1,2]. 
Due to its implausible dietetic and therapeutical 
values, it is known as a “Miracle tree” and has 
been declared as complete and natural nutrition 
for the tropics and famine hit areas [3]. It is a 
prolific producer of diverse secondary 
metabolites including glycosides preferentially 
rhamnosides of carbamates, thiocarbamates, 
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nitriles, benzyl glucosinolates, thiocyanates, 
isothiocyanates and oxazolidine-2-thiones. 
Pharmacological screening of its leaf extracts 
exhibited hypotensive [4], cardioprotective [5], 
hepatoprotective [6], antidiabetic [7] and 
antiulcerogenic activities [8]. The pods are 
hypotensive [9] while seeds showed antibacterial 
[10], antitumor [11], anti-inflammatory and 
antispasmodic activities [12]. Roots were able to 
depress the central nervous system by producing 
analgesia and potentiate the analgesic effect of 
morphine [13]. Aurantiamide acetate and 1,3 
dibenzyl urea  isolated from roots showed 
significant  anti inflammatory, antiarthritic and 
analgesic activity mediated through TNF- alpha, 
interleukin-2 and cytokines inhibition [14]. 
  
 In recent decades therapeutic preparations like 
Septilin for respiratory tract infection, Rumalaya 
for arthralgia and Pro-lacta of M. oleifera have 
been marketed [15]. This paper reports the 
hypotensive evaluation and GC-MS analysis of 
M. oleifera roots constituents detected in winter, 
which are markedly different from those analyzed 
during summer [16]. Earlier volatile constituents 
from leaves [17], flowers [18] and pods [19] of M. 






Fresh roots of M. oleifera (10 kg) were collected 
in November 2007 from HEJ-ICCBS Garden 
University of Karachi, Karachi Pakistan. A 
voucher specimen (no. 66250 KUH) was 
deposited in the herbarium of Department of 
Botany, University of Karachi, where it was 




Fresh roots of M. oleifera was cut into small 
pieces (1 - 2 inch) and successively extracted 
with petroleum ether (PE) and dichloromethane 
(DC) at room temperature for three days. PE 
extract was divided into two layers during 
evaporation. Both layers were separated and 
evaporated to residual masses MRP (upper 
layer, 3.14 g) and MRP - 1 (lower layer, 0.27 g). 
DC extract showed a thick mass settled at the 
bottom of round bottom flask during evaporation 
on rotavapour. It was separated, dried and 
weighed as MRDC - IN (2.25 g). Mother liquor 
left was further evaporated which when 
concentrated divided into two layers. Both layers 
were separated and evaporated to thick 
residues. Upper layer furnished MRDC (4.17 g) 
while lower layer gave MRDC - 1 (8.89 g). 
Gas chromatography mass spectrometry 
 
For GC-MS 6890 N Agilent gas chromatograph 
coupled with a JMS 600 H JEOL mass 
spectrometer was used. The compound mixture 
was separated on a fused silica capillary ZB-5 
column, (30m x 0.32 mm) 0.22 µm film thickness 
in a temperature program from 50 to 260 oC with 
a rate of 4 oC min-1 with 3 min hold. The injector 
was set at 240 oC and the flow rate of helium 
carrier gas was 1 ml min-1. The EI mode JMS 
600 H JEOL mass spectrometer had ionization 
volt 70 eV, electron emission 100 oA. Sample 
was injected manually in split mode. Ratio of 
sample in split mode was 1:50. Identification of  
each extract and fractions were based on  
comparison of their retention indices (RI) 
calculated according to the Kovats formula, using 
n-alkanes (C9 – C33) (sigma –Aldrich, Germany) 
as standards under the same chromatographic 
conditions  and in some cases by co-injection 
with authentic compounds as well as by following 
the characteristic mass fragmentation patterns of 
known  compounds. Retention Indices were also 
compared with literature data available in 
National Institute of Standards and Technology 
Standard Reference Database. The relative 
percentage amount of each component was 
calculated by comparing its average peak area to 




Normotensive Sprague Dawley rats (both sex, 
220 - 250g) were housed in the animal house of 
Dr. HMI Institute of Pharmacology and Herbal 
Sciences in appropriate cages at 21 - 23 oC. 
They were maintained at 12 h of an alternate 
light and dark cycle with free access to water and 
standard diet ad libitum. The maintenance and 
handling of laboratory animals and the 
experiments conducted follow the protocols 
based on internationally accepted standard 
guidelines of the Institutional Ethical Committee. 
The experimental procedures were performed 
according to international guidelines [20] and 
approved by the instutional ethical committee for 
handling laboratory animals (Ref no.  
HU/Dr.HMIIPHS/2013/11).  
   
Hypotensive activity 
 
Rats were anesthetized with urethane (1.2 gm/ 
kg i.p.). The trachea was exposed and 
cannulated with a polyethylene cannula to 
facilitate spontaneous respiration. Drugs were 
injected (0.2 - 0.25 ml) through a polyethylene 
cannula inserted into the extrajuglar vein 
followed by a saline flush (0.2 ml). The arterial 
blood pressure was recorded from the carotid 
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artery via an arterial cannula connected to 
research grade blood pressure transducer 
(Harvard, 60-3003) coupled with four channel 
Harvard oscillograph (Curvilinear, 50-9307)(UK). 
The temperature of the animals was maintained 
at 37 °C by over head heating lamp.  The mean 
blood pressure was calculated as the sum of the 
diastolic blood pressure plus one–third pulse 
width. Changes in blood pressure were 
expressed as the percent of control obtained 
immediately before the administration of test 
substance. Acetylcholine (Ach) (Merck) at a dose 
of 1 µg/kg was used as positive control and 
atropine sulphate (0.1 mg/kg) (C. H. Beohringer 
Sohn Ingelheim Rhein, Germany) as muscarinic 
antagonist. MRP, MRP - 1 and MRDC were 





Changes in blood pressure were compared using 
Students t-test (IBM SPSS Statistics for 
Windows, Version 19.0. Armonk, NY 2010). P < 




GC-MS (vide Tables 1-2) of MRP showed the 
presence of twenty nine compounds including 
five aromatics (1-4, 14), two diterpenes (11, 12), 
an isothiocyanate (21), a steroid (24) and six 
thioureido polymers (13, 15, 17, 19, 22, 23). 
MRP-1 indicated eight compounds specifically 
isocyanate (3), isothiocyanate (21), thioureido 
(23), pyridine (27) and sesquiterpene (28). 
Analysis of MRDC - IN revealed eleven 
constituents, particularly long chain aromatic 
isothiocyanate (21), an aromatic urea (30) and 
three steroids (24, 31 and 32). MRDC (Tables 1-
4) showed the presence of eighteen compounds 
out of which six (33, 36, 40, 45, 46 and 47) 
contained both aromatic and aliphatic moieties. 
GC-MS study of MRDC - 1 detected thirty eight 
compounds together with fourteen aromatics (3, 
10, 33, 46, 48 - 53, 58, 65, 67, 71), one lactone 
(56), one ketone (62) and four aldehydes (63, 66, 
68, 70).  
 
Intravenous administration of extracts in 
anesthetized rats showed changes in systolic, 
diastolic and mean arterial blood pressure 
(MABP). Intravenous injection of positive control 
Ach at the dose of (1 µg/kg) showed (30.63 ± 3.5 
%) fall in MABP while that of normal saline (0.9 
% NaCl) was insignificant. Hypotensive 
evaluation of MRP showed significant fall in 
MABP at 3 mg/kg (41.84 ± 4.74 %, p < 0.01) and 
30 mg/kg (50.06 ± 3.48 %, p < 0.01).  
 
Hypotensive effect was comparable at both 
doses however; duration of activity was 
increased with dose increments (60 sec and 120 
sec) at 3 and 30 mg/kg respectively. MRP - 1 
displayed dose dependent hypotensive effect at 
3 mg/kg (26.2  ± 5.06 %, p < 0.05) and 30 mg/kg 
(42.58 ± 1.21, p < 0.05) with same duration (41 
s) at both doses. MRDC - IN and MRDC - 1 
displayed significant (p < 0.05) dose-dependant 
fall in MABP (28.05 ± 3.04, 49.78 ± 3.83 and 
22.51 ± 1.893, 38.57 ± 0.27 %, respectively at 3 
and 30 mg/kg).  Duration of action increased up 
to 25 min (1500 s) in case of MRDC -IN at higher 
dose while other doses of MRDC - IN and MRDC 
- 1 remained effective for about 34 s.   
 
MRDC showed comparable behavior (46.61 ± 
1.78 and 48.16± 1.79 %, p < 0.05) at both doses 
while duration of action was increased at 30 
mg/kg (95.66 sec) as compared to 3 mg/kg (34 
sec). MRP and MRP - 1 did not show any 
change in MABP when administered in rats 
pretreated with atropine sulphate, however, 
MRDC - IN, MRDC - 1 and MRDC remained 




GC-MS analysis of extracts and fractions 
culminated in the detection of eighty five 
compounds out of which seventy four have been 
identified. Not unexpectedly, hydrocarbons, and 
fatty acid esters were found as commonly 
occurring constituents. Hydrocarbons range from 
C17 to C33 as di, mono and unsubstituted 
compounds. 1, 11 diphenyl undecane (47, 18.78 
%) and cyclopentanyl hexadecane (39, 14.44 %) 
were major hydrocarbon of MRDC. Among fatty 
acid esters, methyl esters dominate and ranges 
from tetradecanoate to tetracosanoate. Methyl 
hexadecanoate (7, 20.3 %) in MRDC and methyl 
14-hydroxy-5-tetradecenoate (9, 19.22 %) in 
MRP - 1 were main esters. Isothiocyanates have 
been detected in all extracts except MRDC while 
halogenated derivatives were identified only in 
MRDC and MRDC – 1.  
 
The characteristic feature of MRP is the 
presence of new and unique thioureido polymers 
(14, 15, 17, 19, 22, 23) that make approximately 
19 % of extract. They exhibited several mass 
fragments with characteristic difference of 74 
amu indicating the possible loss of (-NH-CS-NH)+ 
from corresponding molecular fragments/ 
molecular ion peak. Steroids (approximately 37  
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Table 1: Volatile constituents (1-27) of various extracts of Moringa oleifera roots 
 
S/N Compoundsg Mol. formula 
(M.w) 





















2 2-Amyl furanc (2) C9H14O 
(138) 
987 1001 MS,RI MRP 0.32 
3 p-Tolyl isocyanatea,b (3) C8H9NO 
(133) 






4 Benzamide c (4) C7H7ON 
(121) 
1342 1344 MS,RI MRP 0.46 
5 Octadecane c (5) C18H38 
(254) 




6 Nanodecane b,c (6) C19H40 
(268) 








1935 1933 MS, RI MRP 







8 Ethyl hexadecanoate b,c (8) C18H30O2 
(284) 







tetradecenoate d,e (9) 
C15H28O3 
(256) 













12-ol (trans) d.e (11) 
C20H30O 
(286) 






2341 2315 MS, RI MRP 3.07 
13 Hepta  thioureido- bis -1,1'-
methylene amine e (13) 
C9H22N16S7 
(578) 
2370 - MS MRP 3.56 
14 Ethene 1,1’-bis–p-toulenyl 
sulfide e  (14) 
C16H16S2 
(272) 




15 Octa thioureido- bis-1,1'-
methylene amine e  (15) 
C10H24N18S8 
(652) 
2517 - MS MRP 4.05 
16 Unidentified - 2523  - MRP 2.78 
17 3,7-Dimethyl pentacosane 
d,e  (16) 
C27H56 
(380) 
2612 2608 MS,RI MRP 1.77 
18 Octa thioureido- bis -1,1'- 
methane e   (17) 
C10H22N16S8 
(622) 
2667 - MS MRP 2.03 
19 Tertracosanoic acid b,c  (18) C24H48O2 
(368) 
2725 2685 MS,RI MRP 2.45 
20 Hepta thioureido-bis-1,1'- 
thioamide e (19) 
C9H18N16S9 
(638) 
2778 - MS MRP 2.88 




2764 2773 MS,RI MRP 1.92 
22 15- Phenyl pentadecanyl 
isothiocyanate e (21) 
C22H35NS 
(345) 
2930 - - MRP 
MRP-1 




23 Octa thioureido 1-hydroxy-




3017 - MS MRP 2.89 
24 Unidentified - 3020 - - MRP 2.46 
aMass spectra were compared with literature fragmentation pattern   given  in  National Institute of Standards and 
Technology  Standard Reference Database Number 69; bMass and Retention index comparable  with standard  
compound  injected under similar condition; cMass and Retention index comparable  with values given in  
literature available in  NIST database; dRetention index match with literature  available in NIST database; 
eCompound tentatively identified according to observed mass fragmentation pattern; fRetention index value  
match with non equivalent column; gorder of elution is given on column (ZB-5) 
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Table 2: Volatile constituents (25-46) of various extracts of Moringa oleifera roots  
 
S/N Compoundsg Mol. formula 
(M.w) 




25 Unidentified - 3047 - - MRP 2.47 
26 Benzyl hexathioureido 
propane e (23) 
C16H26N12S6 
(578) 












28 3,7-Dimethyl triacontane 
d,e  (25) 
C32H66 
(450) 
3113 3110 MS, RI MRP 1.14 
29 9,13-Dimethyl  
hentriacontane d,e (26) 
C33H68 
(464) 
3161 3162 MS, RI MRP 1.21 
30 2,5 Diethyl pyridine c (27) C9H13N 
(135) 
1393 1422 MS, RI MRP-1 2.42 
31 1-β-Acetoxy furano-3-
eudesmene d,e   (28) 
C17H24O3 
(276) 
1978 1978 MS, RI MRP-1 4.80 




2581 - MS MRP-1 8.62 
33 Unidentified  - 3058 - - MRP-1 6.94 
34 Unidentified - 2165 - - MRDC-IN 2.65 
35 Unidentified - 2427 - - MRDC-IN 1.88 
36 Unidentified - 2678 - - MRDC-IN 22.27 




2930 - MS MRDC-IN 4.58 
38 Ergosta-5,22-dien-3-ol, 
(3β,22E) c (31) 
C28H46O 
(398) 
3017 3044 - MRDC-IN 9.36 
39 Unidentified - 3033 - - MRDC-IN 10.69 




3044 2981 MS,RI MRDC-IN 7.88 
41 Unidentified - 3056 - - MRDC-IN 7.04 












1674 1666 MS, RI MRDC 0.95 




1708 1706 MS,RI MRDC 1.08 




1969 - MS MRDC 2.51 
46 Methyl (E)-9-
hexadecenoate c (37) 
C17H32O2 
(268) 
1924 1912 MS, RI MRDC 2.961 
aMass spectra were compared with literature fragmentation pattern   given  in  National Institute of Standards and 
Technology  Standard Reference Database Number 69; bMass and Retention index comparable  with standard  
compound  injected under similar condition; cMass and Retention index comparable  with values given in  
literature available in  NIST database; dRetention index match with literature  available in NIST database; 
eCompound tentatively identified according to observed mass fragmentation pattern; fRetention index value  
match with non equivalent column; gorder of elution is given on column (ZB-5) 
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Table 3: Volatile constituents (47-68) of various extracts of Moringa oleifera roots  
 
S/N Compoundsg Mol. formula 
(M.w) 








2085 2073 MS, RI MRDC 6.07 
48 Cyclopentanyl 
hexadecane d,e (39) 
C21H42 
(294) 
2182 2167 RI MRDC 14.44 




2189 2173 MS, RI MRDC 12.0 
50 Methyl (Z)-13-
Octadecenoate d,e (41) 
C19H36O2 
(296) 








2221 2193 RI MRDC 4.10 
52 
 




2312 2365 MS, RI MRDC 7.24 




2439 2434 MS,RI MRDC 5.00 
54 N,N-Dibenzyl-3N- pentyl 
thioureae  (45) 
C20H26N2S 
(326) 
2455 - MS MRDC 5.69 
55 Dibenzyl phthalate c (46) C22H18O4 
(346) 













913 955 RI MRDC-1 0.06 
58 Benzyl thiol c (49) C7H8S 
(124) 
969 1067 MS MRDC-1 0.13 




1281 1320 MS, RI MRDC-1 0.21 
60 Methyl 3,3-diphenyl 
propanoate e  (51) 
C16H16O2 
(240) 
1692 - MS MRDC- 1 0.13 
61 4 (2’-Amino) ethyl benzyl 
isocyanatee  (52)    
C10H12N2O 
(176) 
1781 - MS MRDC-1 0.35 




1789 - MS MRDC-1 0.48 
63 Tetradecanoic acid b,c (54) C14H28O2 
(228) 
1745 1761 MS, RI MRDC-1 0.27 
64 Methyl (Z)-9-
hexadecenoate c (55) 
C17H32O2 
(268) 







2070 MS ,RI MRDC-1 
 
1.053 










2176 2150 MS, RI MRDC-1 4.65 
68 Methyl (Z)-9-
octadecenoated  (59) 
C19H36O2 
(296) 
2146 2106 MS, RI MRDC-1 3.47 
aMass spectra were compared with literature fragmentation pattern   given  in  National Institute of Standards and 
Technology  Standard Reference Database Number 69; bMass and Retention index comparable  with standard  
compound  injected under similar condition; cMass and Retention index comparable  with values given in  
literature available in  NIST database; dRetention index match with literature  available in NIST database; 
eCompound tentatively identified according to observed mass fragmentation pattern; fRetention index value  
match with non equivalent column; gorder of elution is given on column (ZB-5) 
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Table 4: Volatile constituents (69-85) of various extracts of Moringa oleifera roots  
 
S/N Compoundsg Mol. formula 
(M.w) 




69 Methyl  octadecanoated (60) C19H38O2 
(298) 





2250 2279 MS,RI MRDC-1 0.09 
71 2-Docosanone c  (62) C22H44O 
(324) 
2408 2410 MS, RI MRDC-1 
 
1.71 
72 Tricosanal c  (63) C23H46O 
(338) 
2510 2530 MS, RI MRDC-1 
 
1.73 




2602 2607 MS, RI MRDC-1 
 
1.87 
74 1-(p-Benzyl) phenyl -7-
phenyl-1-heptene e (65) 
C27H30 
(354) 
2652 - MS MRDC-1 1.09 
75 Pentacosanal c (66) C25H50O 
(366) 




methyl-4’ phenyl) phenyl -
5– methyl benzene e (67) 
C27H25F 
(368) 
2745 - MS MRDC-1 2.23 
77 Hexacosanal c (68) C26H52O 
(380) 
2789 2830 MS MRDC-1 
 
2.47 
78 Methyl tetracosanoate e (69) C25H50O2 
(382) 
2833  MS MRDC-1 1.04 
79 Heptacosanal c (70) C27H54O 
(394) 
2918 2930 MS MRDC-1 
 
2.17 
80 Unidentified - 2928 - - MRDC-1 3.21 
81 1,4 -Ditoluenyl 2- chloro–5-




3019 - MS MRDC-1 9.09 
82 (Z,Z)-9,18-
Hentriacontadienef  (72) 
C31H60 
(432) 
3070 3055 RI MRDC-1 2.24 






MS, RI MRDC-1 2.06 




3110 3130 MS, RI MRDC-1 0.78 
85 Unidentified - 3154 - - MRDC-1 
 
0.71 
aMass spectra were compared with literature fragmentation pattern   given  in  National Institute of Standards and 
Technology  Standard Reference Database Number 69; bMass and Retention index comparable  with standard  
compound  injected under similar condition; cMass and Retention index comparable  with values given in  
literature available in  NIST database; dRetention index match with literature  available in NIST database; 
eCompound tentatively identified according to observed mass fragmentation pattern; fRetention index value  
match with non equivalent column; gorder of elution is given on column (ZB-5) 
 
%) were observed as main class of compounds 
in MRDC - IN.  MRDC – 1 showed presence of 
most diversified constituents including 
aldehydes, isocyanates, ketone and lactone 
along with other mentioned compounds.   
All extracts and fractions examined showed 
significant hypotensive activity, however, as far 
as mode of action is concerned, PE and DC – 
extracts have opposite behavior. MRP and MRP 
- 1 mediate through muscarinic receptors as both 
did not show any change in MABP in atropine 
pretreated animals. Stimulation of muscarinic 
receptors by MRP and MRP – 1 may cause the 
release of nitric oxide or endothelium derived 
relaxing factors (EDRF) that diffuse in smooth 
muscle cells and initiate immediate decrease in 
MABP. MRDC - IN, MRDC - 1 and MRDC 
appear to espouse pathways other than 
cholinergic. Further research for toxicology and 
exact mode of action is required. 
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The hypotensive activity of non-polar extracts 
and fractions of Moringa oleifera roots and their 
chemical composition through GC-MS have been 
established. However, further studies are needed 
to ascertain its bioactivity, especially in a 
hypertensive model. This will help to establish 
the complementary effect of these components 
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